NGL Fine Chem Share Price

NGL Fine Chem Share Price

NSE: NGLFINE
|
Pharmaceuticals
|
S Cap
₹ 2,844.10
-₹15.30 (-0.54%)
1D
Last updated 23 Sep, 2026, 14:30 IST

NGL Fine Chem Share Price Today

As of 23 Sep 2026, NGL Fine Chem share price is ₹2,844.10. The stock opened at ₹2,838.10, compared to its previous close of ₹2,859.40. During today's trading session, NGL Fine Chem share price moved in the range of ₹2,788.10 to ₹2,858.50, with an average price of ₹2,823.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,271.00 and a high of ₹3,602.00. On the performance front, NGL Fine Chem share price has increased by 30.94% over the last six months and is up 100.94% on a year-on-year basis.

₹2,788.10
0.54% down today
₹2,858.50
1D LOW
1D HIGH

NGL Fine Chem Returns Calculator

Circuit
L
H
₹2,287.60
₹3,431.20
52-week
L
H
₹1,271.00
₹3,602.00

About NGL Fine Chem

NGL Fine Chem Share Price
ISIN
INE887E01022
Sector Market Cap
₹ 1,687.45 Cr

NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.

NGL Fine Chem Financial Highlights

  • Revenue: NGL Fine Chem reported revenue of ₹515.68 crore in FY26 vs ₹376.89 crore in FY25. It showed an increase of 36.83% on a yearly basis.
  • Operating Profit: NGL Fine Chem reported an operating profit of ₹63.37 crore in FY26 vs ₹27.71 crore in FY25. It showed an increase of 128.69% on a year-on-year basis.
  • Net Profit: NGL Fine Chem reported a net profit of ₹48.13 crore in FY26 vs ₹21.12 crore in FY25. It showed an increase of 127.89% on a yearly basis.

NGL Fine Chem Quarterly Result Highlights

  • NGL Fine Chem reported revenue of ₹146.59 crore in Jun 2026, compared with ₹151.69 crore in Mar 2026, representing a decrease of 3.36% on a quarter-on-quarter (QoQ) basis.
  • NGL Fine Chem reported an operating profit of ₹24.48 crore in Jun 2026, compared with ₹17.81 crore in Mar 2026, representing an increase of 37.45% on a quarter-on-quarter (QoQ) basis.
  • NGL Fine Chem reported a profit of ₹18.40 crore in Jun 2026, compared with ₹13.49 crore in Mar 2026, reflecting an increase of 36.40% on a QoQ basis.
  • The earnings per share (EPS) of NGL Fine Chem stood at ₹77.90 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.49%
FII
0.05%
Other DII
0.02%
Retail and other
27.43%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.03%
Jun 20260.05%
Mkt Cap Cr
1,759.23
P/E
30.75
P/B
5.34
ROE
14.62%
D/E
0.34
ROCE
15.37%
Div. Yield
0.06%
EPS(TTM)
67.39
Turnover
0.99
EV/EBITDA
17.93
Net Margin
9.56%
Op. Margin
16.96%
ROA
10.49%
Quick Ratio
1.37
Curr. Ratio
2.86
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
NGL Fine Chem outperforming most market indices
Step 1 of 5
Valuation
Overvalued
NGL Fine Chem appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
NGL Fine Chem revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

NGL Fine Chem Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹500.95₹368.26₹338.69₹278.08
Other Income₹14.73₹8.63₹14.13₹5.53
Total Revenue₹515.68₹376.89₹352.82₹283.61
Total Expenses₹452.32₹349.17₹298.40₹256.25
Profit Before Tax₹63.37₹27.71₹54.42₹27.36
Tax₹15.24₹6.59₹13.10₹6.87
Profit After Tax₹48.13₹21.12₹41.32₹20.50
EPS - Basic₹77.90₹34.19₹66.88₹33.18
EPS - Diluted₹77.90₹34.19₹66.88₹33.18

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹63.37₹27.71₹54.42₹27.36
Income before WC changes₹89.22₹40.83₹66.18₹38.89
Change in Assets-₹59.57-₹20.35-₹59.03₹16.05
Change in Liabilities₹28.91₹18.46₹26.41-₹12.79
Change in WC-₹30.66-₹1.89-₹32.62₹3.26
Cash flow from Operations₹43.32₹32.35₹20.47₹35.29
Cash flow from Investing-₹70.59-₹69.68-₹26.82-₹27.02
Cash flow from Financing₹29.55₹37.47-₹1.08-₹1.08
Total Cash Flow₹2.27₹0.14-₹7.43₹7.18
Cash (Start of the year)₹0.53₹0.40₹7.83₹0.64
Cash (End of the year)₹2.81₹0.53₹0.40₹7.83

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹269.11₹200.80₹142.87₹124.42
Current Assets₹276.39₹233.88₹212.67₹162.66
Total Assets₹545.50₹434.68₹355.54₹287.08
Current Liabilities₹150.01₹118.42₹86.59₹58.29
Net Current Asset₹126.38₹115.46₹126.08₹104.36
Non-Current Liabilities₹66.25₹33.83₹6.32₹6.24
Equity Capital₹329.24₹282.43₹262.63₹222.55
Total Equity & Liabilities₹545.50₹434.68₹355.54₹287.08

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹488.77₹359.29₹328.97₹275.05
Other Income₹14.85₹9.76₹15.90₹7.61
Total Revenue₹503.63₹369.05₹344.87₹282.66
Total Expenses₹449.01₹345.17₹294.17₹256.07
Profit Before Tax₹54.62₹23.88₹50.71₹26.60
Tax₹12.99₹5.75₹12.19₹6.48
Profit After Tax₹41.63₹18.13₹38.52₹20.12
EPS - Basic₹67.39₹29.35₹62.35₹32.57
EPS - Diluted₹67.39₹29.35₹62.35₹32.57

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹54.62₹23.88₹50.71₹26.60
Income before WC changes₹76.55₹32.59₹49.58₹32.51
Change in Assets-₹57.02-₹21.72-₹51.94₹18.04
Change in Liabilities₹28.19₹16.87₹25.68-₹12.18
Change in WC-₹28.83-₹4.85-₹26.26₹5.86
Cash flow from Operations₹34.73₹21.99₹11.14₹31.89
Cash flow from Investing-₹64.57-₹58.20-₹17.49-₹23.62
Cash flow from Financing₹29.87₹36.35-₹1.08-₹1.08
Total Cash Flow₹0.03₹0.14-₹7.44₹7.19
Cash (Start of the year)₹0.52₹0.39₹7.82₹0.64
Cash (End of the year)₹0.55₹0.52₹0.39₹7.82

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹264.38₹198.20₹149.35₹128.92
Current Assets₹265.25₹227.56₹203.69₹159.19
Total Assets₹529.63₹425.76₹353.05₹288.11
Current Liabilities₹144.03₹112.96₹84.36₹56.65
Net Current Asset₹121.22₹114.60₹119.33₹102.54
Non-Current Liabilities₹65.66₹33.19₹5.88₹5.94
Equity Capital₹319.94₹279.61₹262.81₹225.52
Total Equity & Liabilities₹529.63₹425.76₹353.05₹288.11
* All values are in INR Crore
Qty
Bid
1
2839.1
1
2838.2
1
2838.1
1
2836.4
4
2836.3
Ask
Qty
2847
1
2847.5
1
2847.6
1
2847.7
2
2847.8
1
Bid Total: 8
Ask Total: 6
Buy orders: 57%
Sell orders: 43%
Bearish
4
Neutral
4
Bullish
0
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
50.41
Neutral
ATR (14)
146.34
Neutral
STOCH(9,6)
95.78
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
30.87
Bearish
UO(9)
60.09
Neutral
ROC(12)
-2.77
Bearish
WillR(14)
-28.38
Neutral
Period
Simple value
Exponential vaue
5D
2749.66
2768.41
10D
2728.29
2759.4
20D
2769.78
2811.24
50D
3037.63
2910.42
100D
2903.08
2817.97
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
NGL Fine Chem Share Price
NGL Fine Chem
Pharmaceuticals
Add Stock
Add Another

NGL Fine Chem Share Price FAQs

NGL Fine Chem share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837